Particle.news

Download on the App Store

XFG Variant Now Drives Nearly Half of Global COVID-19 Cases

Global health authorities maintain a low-risk rating following evidence of stable severity with sustained vaccine protection

Overview

  • WHO’s Technical Advisory Group on Virus Evolution continues to list XFG as a Variant Under Monitoring due to its rapid expansion but low additional risk
  • First identified on January 27, 2025, XFG arose from recombination of Omicron sublineages LF.7 and LP.8.1.2 and has been detected in at least 38 countries
  • Clinical data indicate XFG infections do not increase hospitalizations or severe disease and often include typical COVID-19 symptoms plus transient hoarseness
  • Declining booster coverage and waning population immunity are cited as key factors behind XFG’s rise to about 48% of global sequences by July 20
  • Mexico has yet to report any confirmed XFG cases as WHO-led genomic surveillance continues